Blue Cross of Massachusetts to Change Pharmacy Providers
Effective January 2023, the organization will switch from Express Scripts to CVS Caremark.
Blue Cross Blue Shield of Massachusetts has announced a new relationship with CVS Caremark, the pharmacy benefit management business of CVS Health. Beginning January 1, 2023, CVS Caremark will support Blue Cross in managing pharmacy benefit services for its commercial and Medicare groups and individual health plans.
Andrew Dreyfus
“We’re working hard to simplify the pharmacy experience, improve health outcomes, and lower costs for our customers and members, and our partnership with CVS Caremark will help us advance that work,” Andrew Dreyfus, president and CEO of Blue Cross Blue Shield of Massachusetts, said in a statement.
The new agreement is expected to generate cumulative pharmacy savings for Blue Cross customers of between 10% to 15% over the course of the three-year contract. CVS Caremark will support the processing of pharmacy claims, negotiate contracting with pharmaceutical manufacturers on behalf of Blue Cross, offer mail-order dispensing and other pharmacy network options for Blue Cross members.
The organization’s current PBM is Express Scripts.
Blue Cross is the largest private health plan in Massachusetts with 2.8 million members.
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
PBM-Offered Genomics Testing Could Reshape Prescribing of Medications
August 3rd 2025Two PBMs, True Rx Health Strategies and Capital Rx, are using pharmacogenomics — how a person’s DNA affects their response to medications — to reduce the trial-and-error of prescribing medications, saving employers and patients time and money.
Read More
FDA Extends Review of Blenrep Combinations in Multiple Myeloma
August 3rd 2025Last week, an FDA advisory committee against the risk-benefit profile of Blenrep in combination with other therapies. Regulators and reviewers were concerned about the ocular side effects and dosing and tolerability. The new action date is Oct. 23, 2025.
Read More
